Activation of mitogen-activated protein kinase pathway by keratinocyte growth factor or fibroblast growth factor-10 promotes cell proliferation in human endometrial carcinoma cells.
about
FGF-10 and its receptor exhibit bidirectional paracrine targeting to urothelial and smooth muscle cells in the lower urinary tractFgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomasFunctional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma.Conditional deletion of N-Myc disrupts neurosensory and non-sensory development of the ear.Inferring pathway dysregulation in cancers from multiple types of omic data.Mechanisms of KGF mediated signaling in pancreatic duct cell proliferation and differentiation.Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.Fibroblast growth factor-5 participates in the progression of hepatic fibrosis.TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.The loss of Tm7sf gene accelerates skin papilloma formation in miceNeuron-derived FGF10 ameliorates cerebral ischemia injury via inhibiting NF-κB-dependent neuroinflammation and activating PI3K/Akt survival signaling pathway in miceInnate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens.Fibroblast growth factors 7 and 10 are involved in ameloblastoma proliferation via the mitogen-activated protein kinase pathwayPotential dual role of KGF/KGFR as a target option in novel therapeutic strategies for the treatment of cancers and mucosal damages.Keratinocyte Growth Factor Regulation of Aryl Hydrocarbon Receptor Activation in Colorectal Cancer Cells.Traditional Approaches to Molecular Genetic Analysis.Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines.Fibroblast growth factor-10 prevents asbestos-induced alveolar epithelial cell apoptosis by a mitogen-activated protein kinase-dependent mechanism.FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities.Palifermin for management of treatment-induced oral mucositis in cancer patients.FGF5 is expressed in melanoma and enhances malignancy in vitro and in vivo.Fibroblast Growth Factor 7 Regulates Proliferation and Decidualization of Human Endometrial Stromal Cells via ERK and JNK Pathway in an Autocrine Manner.Exogenous FGF10 can rescue an eye-open at birth phenotype of Fgf10-null mice by activating activin and TGFalpha-EGFR signaling.Graft-versus-tumor effects on murine mammary carcinoma in a model of nonmyeloablative haploidentical stem cell transplantation.Regulation of FGF10 Signaling in Development and Disease
P2860
Q24314647-D51FBED9-484A-4372-8E02-2F02E4269FBAQ28267846-6D2D4CB7-593F-480F-B6DF-1FE2265037A9Q30445148-D3EBFAB2-F622-4FB9-8C23-1C202B2EAE82Q30500202-28E91BF3-8D76-4F2F-B126-A9B2AC7104A7Q30980125-14846CC8-4EB4-4B43-9B1D-D3029E1440FFQ33415468-D8A7D65F-ADDB-465E-86BC-603C513FFB5AQ33985578-6B3BBDCB-97B6-43E8-92CE-EFA1377A6BD2Q34163582-DE0F4DE5-1539-490E-90E4-4B2BFAC21870Q34756109-03AEEBC9-99E9-4D42-A9E9-632268CE818BQ35214901-FD5303BB-6F45-4387-A324-E3B31AEFB749Q36507092-009D9243-D2FA-4F79-9B38-53610C930D97Q37280601-9931E9B5-859A-4D6F-8A2E-3D185647961DQ37296137-3BD7B524-B7BB-4EF9-A593-CE62AA2177ADQ37996468-8798CB34-F3D5-4918-9E16-2B11A01CCD0CQ38823864-1A6105ED-E2CD-4360-8CC2-6D07800C7974Q39026764-2BE7DA73-7FAE-49DB-891D-6AE099B885CBQ40333931-BA689226-C84C-4EB7-8557-C1E31B2A0BA6Q40477277-90F0A125-D68E-45CC-BF50-EA7DA8C90D90Q40855352-BD64A377-FF9C-460F-BD7A-292662299E87Q42052507-48924D89-EBA5-4446-86BD-2F45613695E4Q47160915-6BE06E28-8E49-4420-83A8-C68C6318917AQ51107709-C51056F6-9ADE-4721-994D-53622D79D94BQ51185489-5394A698-FE33-4025-9B21-FC1A27D38417Q53622248-1F97D2A3-52F5-4CE9-A093-51F3CD9222E7Q58572262-193082B8-B54D-4A88-94AA-950A5F493789
P2860
Activation of mitogen-activated protein kinase pathway by keratinocyte growth factor or fibroblast growth factor-10 promotes cell proliferation in human endometrial carcinoma cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Activation of mitogen-activate ...... n endometrial carcinoma cells.
@en
Activation of mitogen-activate ...... n endometrial carcinoma cells.
@nl
type
label
Activation of mitogen-activate ...... n endometrial carcinoma cells.
@en
Activation of mitogen-activate ...... n endometrial carcinoma cells.
@nl
prefLabel
Activation of mitogen-activate ...... n endometrial carcinoma cells.
@en
Activation of mitogen-activate ...... n endometrial carcinoma cells.
@nl
P2093
P356
P1476
Activation of mitogen-activate ...... n endometrial carcinoma cells.
@en
P2093
Fuminori Taniguchi
Naoki Terakawa
Nobuhiro Yamauchi
Souichi Yoshida
Tasuku Harada
Tomio Iwabe
Yasuko Sakamoto
P304
P356
10.1210/JC.2002-021062
P407
P577
2003-02-01T00:00:00Z